CRISPR 3.0: The Next Generation of Gene Editing Is Here
Researchers announce CRISPR 3.0, a next-generation gene editing platform with 100-fold improved precision that could revolutionize longevity interventions.
Scientists at UNSW Sydney have developed a gentler form of CRISPR that can turn genes back on by removing chemical...
UNSW Sydney researchers develop CRISPR technique that activates silenced genes by removing methyl groups, avoiding the...
A single infusion of base-edited cells eliminates symptoms in 12 patients, marking a new era for genetic medicine.
NVIDIA and pharmaceutical giant Eli Lilly form a landmark five-year partnership to build an AI co-innovation lab,...
DeepMind's latest AI model can now predict how drugs bind to proteins, potentially cutting years off the drug...
AI platform screens billions of compounds to find promising senolytic molecules, compressing years of drug discovery...
Sam Altman-backed longevity startup Retro Biosciences doses first participant in Phase 1 trial of RTR242, a therapy...
Rejuvenate Bio initiates a groundbreaking clinical trial testing a gene therapy cocktail designed to reverse multiple...
Low-dose rapamycin improves vaccine response and reduces infections in older adults, suggesting broader anti-aging...